Protein ‘map’ could lead to potent new cancer drugs
Posted on 29 September 2014
Scientists at the University of York are part of a team of researchers which has gained fresh insights into how a disease-causing enzyme makes changes to proteins and how it can be stopped.
The scientists in York Structural Biology Laboratory (YSBL) in the University’s Department of Chemistry hope their findings will help them to design drugs that could target the enzyme, known as N-myristoyltransferase (NMT), and potentially lead to new treatments for cancer and inflammatory conditions. See
http://www.york.ac.uk/news-and-events/news/2014/research/enzyme-research-cancer/ for more details